Observational studySurgical endoscopy2026
Safety and feasibility of solo surgery using a novel robotic platform: an IDEAL 2a development study.
Observational study in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Emerging robotic platforms in gynecologic surgery: a systematic review.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimally invasive surgery is the standard of care for general surgical procedures. While use continues to grow, current platforms are hindered by prolonged operative times, high costs, steep learning curves, and lack of surgeon autonomy, which restricts expansion and practicality in high-volume and ambulatory surgery centers. Our goal was to evaluate the safety and feasibility of a novel AI-powered robotic platform to perform solo surgery.
methodsAn IDEAL framework 2a prospective, multi-center observational study was performed on consecutive patients planned for solo abdominal surgery using the Maestro™ robotic system (Moon Surgical SAS, Paris, France) from 10/2023 to 4/2025. Preoperative, intraoperative, postoperative, and device-specific variables were evaluated. Descriptive statistics were used to summarize outcome measures.
resultsForty-five procedures were performed by five surgeons. Patients had a mean age of 55.3 (SD 18.1) years and a mean BMI of 29.4 (8.1) kg/m
conclusionThis IDEAL 2a investigation showed the Maestro platform was safe and feasible for performing solo surgery, with acceptable safety and technical outcomes in routine and complex procedures. There is potential to improve operating room workflow and surgeon autonomy, with controlled studies to follow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.